Invasive pneumococcal disease in the immunocompromised host.
暂无分享,去创建一个
[1] J. Ojoo,et al. Responsiveness of human immunodeficiency virus type 1-infected Kenyan women with or without prior pneumococcal disease to pneumococcal vaccine. , 1997, The Journal of infectious diseases.
[2] D. Musher,et al. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] D. Musher,et al. Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. , 1997, The Journal of infectious diseases.
[4] D. Rimland,et al. Community‐acquired bacteremia in HIV‐positive patients: protective benefit of co‐trimoxazole , 1996, AIDS.
[5] S. Swindells,et al. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. , 1996, The Journal of infectious diseases.
[6] F. Altice,et al. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] D. Craven,et al. Causes of fever in patients infected with human immunodeficiency virus who were admitted to Boston City Hospital. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] T. Peláez,et al. Recurrent pneumococcal bacteremia. A warning of immunodeficiency. , 1996, Archives of internal medicine.
[9] G. Castellani,et al. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] W. Timens,et al. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. , 1996, The Journal of allergy and clinical immunology.
[11] F. Plummer,et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya , 1996, The Lancet.
[12] M. Guiguet,et al. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] D. Musher,et al. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] M. Steinhoff,et al. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. , 1996, The Journal of infectious diseases.
[15] J. Eskola,et al. New vaccines for prevention of pneumococcal infections. , 1996, Annals of medicine.
[16] P. Hopewell,et al. Impaired natural immunity to pneumolysin during human immunodeficiency virus infection in the United States and Africa. , 1995, American journal of respiratory and critical care medicine.
[17] M. Goldman,et al. Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine. , 1995, The Journal of infectious diseases.
[18] J. Paul,et al. Streptococcus pneumoniae resistant to penicillin and tetracycline associated with HIV seropositivity , 1995, The Lancet.
[19] Richard D Moore,et al. Community-acquired pneumonia: impact of immune status. , 1995 .
[20] S. Miller,et al. Anti-pneumococcal antibody levels three to seven years after first booster immunization in children with sickle cell disease, and after a second booster. , 1995, The Journal of pediatrics.
[21] R. Hirschtick,et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. , 1995, The New England journal of medicine.
[22] E. Janoff,et al. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. , 1995, The Journal of infectious diseases.
[23] P. Hopewell,et al. Impact of Streptococcus pneumoniae bacteremia and human immunodeficiency virus type 1 on oral mucosal immunity. , 1995, The Journal of infectious diseases.
[24] P. Van Royen,et al. Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease. , 1995, The Journal of infectious diseases.
[25] K. Holmes,et al. Reducing the impact of opportunistic infections in patients with HIV infection. New guidelines. , 1995, JAMA.
[26] J. Ruiz-Contreras,et al. Sepsis in children with human immunodeficiency virus infection. The Madrid HIV Pediatric Infection Collaborative Study Group. , 1995, The Pediatric infectious disease journal.
[27] M. Wallace,et al. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine. , 1995, The Journal of infectious diseases.
[28] C. Giaquinto,et al. Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection. , 1995, The Pediatric infectious disease journal.
[29] P. Moore,et al. Risk factors for adverse outcome in persons with pneumococcal pneumonia. , 1995, Chest.
[30] P. Andrew,et al. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. , 1995, The Journal of clinical investigation.
[31] R. Gelber,et al. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. , 1994, The New England journal of medicine.
[32] R. Lütticken,et al. Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patients. , 1994, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[33] D. Musher,et al. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. , 1994, The New England journal of medicine.
[34] D. Niewoehner,et al. Pneumolysin activates phospholipase A in pulmonary artery endothelial cells , 1994, Infection and immunity.
[35] P. Selwyn,et al. Medical care for injection-drug users with human immunodeficiency virus infection. , 1994, The New England journal of medicine.
[36] H. Gayle,et al. The public health implications of AIDS research in Africa. , 1994, JAMA.
[37] W. Borkowsky,et al. Streptococcus pneumoniae in human immunodeficiency virus type 1‐infected children , 1994, The Pediatric infectious disease journal.
[38] D. Parks,et al. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention. , 1994, The Journal of infectious diseases.
[39] T. Marrie. Pneumonia and carcinoma of the lung. , 1994, The Journal of infection.
[40] E. Janoff,et al. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine. , 1994, The Journal of pediatrics.
[41] R. Tressler,et al. Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection. , 1994, The Journal of pediatrics.
[42] W. Andiman,et al. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1. , 1994, The Journal of pediatrics.
[43] L. Mofenson,et al. Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus‐infected children , 1994, The Pediatric infectious disease journal.
[44] J. D. de Jong,et al. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV‐seropositive individuals in relation to the number of CD4+ lymphocytes , 1994, AIDS.
[45] I. Ocaña,et al. Bacterial pneumonia in HIV-infected patients: a prospective study of 68 episodes. , 1994, The European respiratory journal.
[46] F. Rodeghiero,et al. Fulminant sepsis in adults splenectomized for Hodgkin's disease. , 1993, Haematologica.
[47] J. Rubins,et al. Identification of hydrogen peroxide as a Streptococcus pneumoniae toxin for rat alveolar epithelial cells , 1993, Infection and Immunity.
[48] M. Falguera,et al. Prevalence and outcome of pneumococcal carrier human immunodeficiency virus-infected patients. , 1993, The Journal of infectious diseases.
[49] D. Musher,et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[50] D. Jarjoura,et al. Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. , 1993, Chest.
[51] I. Julander,et al. Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations--Huntington, WVa, and Stockholm, Sweden. , 1993, Chest.
[52] H. Sacks,et al. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. , 1993, The American journal of medicine.
[53] J. Lortan,et al. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults , 1993, Clinical and experimental immunology.
[54] P. Thompson,et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. , 1993, The Journal of infectious diseases.
[55] H. Waskin,et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. , 1992, The New England journal of medicine.
[56] M. Drucker,et al. Epidemiology of Invasive Childhood Pneumococcal Infections in Israel , 1992 .
[57] M. Leinonen,et al. Epidemiology of invasive pneumococcal infections in children in Finland. , 1992, JAMA.
[58] R. Dagan,et al. Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. , 1992, JAMA.
[59] P. Selwyn,et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. , 1992, The New England journal of medicine.
[60] W. Gransden,et al. Recurrent pneumococcal bacteremia. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[61] D. Kilpatrick. Soluble interleukin-2 receptors in recurrent miscarriage and the effect of leukocyte immunotherapy. , 1992, Immunology letters.
[62] D. Wara,et al. Low number of antibody producing cells in patients with sickle cell anemia. , 1992, Immunology letters.
[63] Fenguangzhai Song. CD , 1992 .
[64] N. Bennett,et al. Pneumococcal bacteremia in Monroe County, New York. , 1992, American journal of public health.
[65] M. Santosham,et al. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. , 1992, Archives of internal medicine.
[66] E. Bouza,et al. Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. , 1992, Archives of internal medicine.
[67] P. Hopewell,et al. Pneumococcal Disease during HIV Infection , 1992, Annals of Internal Medicine.
[68] L. Mofenson,et al. Prophylactic Intravenous Immunoglobulin in HIV-Infected Children With CD4+ Counts of 0.20×109/L or More: Effect on Viral, Opportunistic, and Bacterial Infections , 1992 .
[69] J. Moye,et al. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. , 1992, JAMA.
[70] J. Rubins,et al. Toxicity of pneumolysin to pulmonary endothelial cells in vitro , 1992, Infection and immunity.
[71] F. Claas,et al. The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide. , 1992, Immunology letters.
[72] H. Helenius,et al. Infections and serum IgG levels in patients with chronic lymphocytic leukemia , 1992, European journal of haematology.
[73] D. K. Kelsey,et al. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci. , 1992, Journal of immunology.
[74] M. Daha,et al. An association between homozygous C3 deficiency and low levels of anti‐pneumococcal capsular polysaccharide antibodies , 1992, Clinical and experimental immunology.
[75] G. Overturf,et al. Polysaccharide encapsulated bacterial infection in sickle cell anemia: A thirty year epidemiologic experience , 1992, American journal of hematology.
[76] V. Valtonen,et al. Pneumococcal bacteraemia during a recent decade. , 1992, The Journal of infection.
[77] D. Musher,et al. Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[78] R. van Furth,et al. Mechanisms of host defense against infection with Streptococcus pneumoniae. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[79] G. Pesola,et al. Pneumococcal bacteremia with pneumonia. Mortality in acquired immunodeficiency syndrome. , 1992, Chest.
[80] D. Vlahov,et al. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. , 1991, The New England journal of medicine.
[81] R. Adair,et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. , 1991, The New England journal of medicine.
[82] G. Boulnois,et al. Structure and function of pneumolysin, the multifunctional, thiol‐activated toxin of Streptococcus pneumoniae , 1991, Molecular microbiology.
[83] P. D. Smith,et al. Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG. , 1991, Journal of immunology.
[84] R. Auckenthaler,et al. Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients. , 1991, The American review of respiratory disease.
[85] G. Schiffman,et al. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. , 1991, The Journal of infectious diseases.
[86] L. Mofenson,et al. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. , 1991, The New England journal of medicine.
[87] P. Densen,et al. Infectious diseases associated with complement deficiencies , 1991, Clinical Microbiology Reviews.
[88] W. Levine,et al. Epidemiology of nontyphoidal Salmonella bacteremia during the human immunodeficiency virus epidemic. , 1991, The Journal of infectious diseases.
[89] A. Schuchat,et al. Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population. , 1991, JAMA.
[90] M. Opravil,et al. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV‐infected patients , 1991, Clinical and experimental immunology.
[91] J. Henrichsen,et al. Pneumococcal Infections in Splenectomized Children Are Preventable , 1991, Acta paediatrica Scandinavica.
[92] C. Leport,et al. Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS. , 1991, The Journal of infectious diseases.
[93] F. Puppo,et al. Major histocompatibility gene products and human immunodeficiency virus infection. , 1991, The Journal of laboratory and clinical medicine.
[94] I. Abramson,et al. The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. , 1991, The Journal of infectious diseases.
[95] G. Rutherford,et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. , 1990, The Journal of infectious diseases.
[96] D. Warrell,et al. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya , 1990, The Lancet.
[97] R. Breiman,et al. Pneumococcal bacteremia in Charleston County, South Carolina. A decade later. , 1990, Archives of internal medicine.
[98] E. Winsor,et al. Neutrophil dysfunctions in sickle cell disease. , 1990, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[99] Y. Sultan,et al. Dexamethasone treatment for bacterial meningitis in children and adults , 1989, The Pediatric infectious disease journal.
[100] P. Casali,et al. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. , 1989, Immunology today.
[101] L. Hammarström,et al. Type‐specific anti‐pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients , 1989, European journal of haematology.
[102] P. Selwyn,et al. Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus. , 1989, The Journal of infectious diseases.
[103] S. Frøland,et al. Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV). , 1989, Clinical and experimental immunology.
[104] J. Bogaerts,et al. Bacteraemia as Predictor of HIV Infection in African Children , 1989, Acta paediatrica Scandinavica.
[105] E. Tuomanen,et al. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes , 1989, The Journal of experimental medicine.
[106] L. Specht,et al. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease , 1989, European journal of haematology.
[107] H. Krumholz,et al. Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. , 1989, The American journal of medicine.
[108] S. Gillespie. Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. , 1989, Journal of medical microbiology.
[109] F. Miedema,et al. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection , 1989, European journal of immunology.
[110] C. Schraer,et al. Invasive pneumococcal disease in an Alaska native population, 1980 through 1986. , 1989, JAMA.
[111] F. Lamothe,et al. Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics , 1989, Journal of clinical microbiology.
[112] J. Falloon,et al. Human immunodeficiency virus infection in children. , 1989, The Journal of pediatrics.
[113] M. Cairo,et al. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. , 1988, The Journal of infectious diseases.
[114] M. Blaser,et al. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. , 1988, The Journal of infectious diseases.
[115] A. Randomized. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. , 1988 .
[116] A. Fauci,et al. Impairment of neutrophil bactericidal capacity in patients with AIDS. , 1988, The Journal of infectious diseases.
[117] P. Selwyn,et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. , 1988, AIDS.
[118] W. Borkowsky,et al. Bacterial infections in human immunodeficiency virus‐infected children , 1988, The Pediatric infectious disease journal.
[119] M. Blaser,et al. Acute antibody responses to Giardia lamblia are depressed in patients with AIDS. , 1988, The Journal of infectious diseases.
[120] J. Hermans,et al. Pneumococcal bacteremia in adults over a 10-year period at University Hospital, Leiden. , 1988, Reviews of infectious diseases.
[121] R. Holman,et al. Hypergammaglobulinemia associated with human immunodeficiency virus infection. , 1988, Monographs in allergy.
[122] E. Garin,et al. Pneumococcal polysaccharide immunization in patients with active nephrotic syndrome. , 1988, Nephron.
[123] G. Schiffman,et al. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides. , 1987, Clinical immunology and immunopathology.
[124] E. Shapiro,et al. Prevention of pneumococcal bacteremia in a child with acquired immunodeficiency syndrome‐related complex , 1987, The Pediatric infectious disease journal.
[125] P. Toghill,et al. Bacteraemia in adults after splenectomy or splenic irradiation. , 1987, The Quarterly journal of medicine.
[126] W. R. Mccabe,et al. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. , 1987, The American journal of medicine.
[127] L. Kingsley,et al. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. , 1987, JAMA.
[128] T. Quinn,et al. Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome. , 1987, The Journal of clinical investigation.
[129] T. Shah,et al. Polymorphonuclear leukocyte-mediated, antibody-dependent cellular cytotoxicity in patients with AIDS. , 1987, The Journal of infectious diseases.
[130] J. Lobel,et al. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency. , 1987, The Journal of clinical investigation.
[131] J. Kersey,et al. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. , 1986, The Journal of infectious diseases.
[132] R. Schreiber,et al. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. , 1986, The Journal of clinical investigation.
[133] J. Verter,et al. Bacteremia in sickle hemoglobinopathies. , 1986, The Journal of pediatrics.
[134] I. Maclennan,et al. Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA. , 1986, Clinical and experimental immunology.
[135] E Vichinsky,et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. , 1986, The New England journal of medicine.
[136] J. Spika,et al. Decline of vaccine-induced antipneumococcal antibody in children with nephrotic syndrome. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[137] M. Hostetter,et al. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. , 1986, The Journal of infectious diseases.
[138] L. Hammarström,et al. Pneumococcal antibodies of different immunoglobulin subclasses in normal and IgG subclass deficient individuals of various ages. , 1986, Acta oto-laryngologica.
[139] B. Polsky,et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.
[140] S. Sarnaik,et al. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia. , 1986, The American journal of pediatric hematology/oncology.
[141] D. Rimland,et al. Alcoholism, leukopenia, and pneumococcal sepsis. , 2015, The American review of respiratory disease.
[142] J. Lobel,et al. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease. , 1985, The Journal of infectious diseases.
[143] P. Drew,et al. Lack of effect of splenic regrowth on the reduced antibody responses to pneumococcal polysaccharides in splenectomized patients. , 1985, Clinical and experimental immunology.
[144] D. Gray,et al. Class and subclass anti-pneumococcal antibody responses in splenectomized patients. , 1985, Clinical and experimental immunology.
[145] A. Rubinstein,et al. Bacterial infection in the acquired immunodeficiency syndrome of children , 1985, Pediatric infectious disease.
[146] T. Quinn,et al. Defective reticuloendothelial system Fc-receptor function in patients with acquired immunodeficiency syndrome. , 1985, The Journal of infectious diseases.
[147] P. Schur,et al. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. , 1985, The Journal of clinical investigation.
[148] R. Norrby,et al. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. , 1985, Reviews of infectious diseases.
[149] I. Phillips,et al. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. , 1985, British medical journal.
[150] F. D. Di Padova,et al. Impaired antipneumococcal antibody production in patients without spleens. , 1985, British medical journal.
[151] G. Schiffman,et al. Pneumococcal vaccination in children with acute lymphocytic leukemia. , 1985, Medical and Pediatric Oncology.
[152] P. Densen,et al. Complement Deficiency States and Infection: Epidemiology, Pathogenesis and Consequences of Neisserial and Other Infections in an Immune Deficiency , 1984, Medicine.
[153] B. Cheson,et al. Defective binding of the third component of complement (C3) to Streptococcus pneumoniae in multiple myeloma. , 1984, Blood.
[154] P. Volberding,et al. B-cell immunodeficiency in acquired immune deficiency syndrome. , 1984, JAMA.
[155] W. Parks,et al. Acquired immunodeficiency syndrome in infants. , 1984, The New England journal of medicine.
[156] J. Mestecky,et al. Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. , 1984, Journal of immunology.
[157] G. Murata,et al. Community-acquired bacterial pneumonias in homosexual men: presumptive evidence for a defect in host resistance. , 1984, AIDS research.
[158] J. Winkelstein,et al. Complement and the host's defense against the pneumococcus. , 1984, Critical reviews in microbiology.
[159] M. Chou,et al. Severe pneumococcal infection in patients with neoplastic disease , 1983, Cancer.
[160] A. Fauci,et al. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. , 1983, The Journal of clinical investigation.
[161] B. J. OʼNeal,et al. The risk of sepsis in the asplenic adult , 1982 .
[162] H. Masur,et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. , 1981, The New England journal of medicine.
[163] P. Baker,et al. Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells. , 1981, Reviews of infectious diseases.
[164] S. Weitzman,et al. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. , 1980, The New England journal of medicine.
[165] S. Feig,et al. Pneumococcal infections after human bone-marrow transplantation. , 1979, Annals of internal medicine.
[166] R. Johnston,et al. Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. , 1978, The New England journal of medicine.
[167] M. Burr,et al. Letter: Effects of age and intake on plasma-ascorbic-acid levels. , 1974, Lancet.
[168] J. Twomey. Infections complicating multiple myeloma and chronic lymphocytic leukemia. , 1973, Archives of internal medicine.
[169] J. Hobbs. Hypogammaglobulinaemia in the United Kingdom , 1972 .
[170] R. Austrian,et al. PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. , 1964, Annals of internal medicine.
[171] C. Janeway,et al. The gamma globulins. , 1966, Advances in pediatrics.